Despite the help of so many groups and volunteers,
startup costs in each country are a huge
challenge. Fortunately, DREAM has been able to
obtain approved drugs at a much lower price than
is possible in the USA and Europe. The annual per
patient cost for drug therapy is only three hundred
dollars, a comparatively small sum in the USA but close to the total annual income of many
Africans.